{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:31:13Z","timestamp":1715819473736},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ijcard.2024.132076","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:27:53Z","timestamp":1713666473000},"page":"132076","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Response to \u201cCharacteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants\u201d"],"prefix":"10.1016","volume":"407","author":[{"given":"Parham","family":"Sadeghipour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadhossein","family":"Mozafarybazargany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody","family":"Farrashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijcard.2024.132076_bb0005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa2209051","article-title":"Rivaroxaban in rheumatic heart disease\u2013associated atrial fibrillation","volume":"387","author":"Connolly","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9745","key":"10.1016\/j.ijcard.2024.132076_bb0010","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2024.132076_bb0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2022.03.037","article-title":"RIvaroxaban in mitral stenosis (RISE MS): a pilot randomized clinical trial","volume":"356","author":"Sadeghipour","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132076_bb0020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1536\/ihj.38.669","article-title":"Thromboembolism risk in patients with mitral stenosis","volume":"38","author":"Acart\u00fcrk","year":"1997","journal-title":"Jpn. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132076_bb0025","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0002-9149(96)00828-4","article-title":"Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram","volume":"79","author":"Leung","year":"1997","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732400696X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732400696X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T06:47:06Z","timestamp":1715755626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732400696X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":5,"alternative-id":["S016752732400696X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132076","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response to \u201cCharacteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants\u201d","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"132076"}}